Status:
COMPLETED
Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Gestational Diabetes
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate whether Continuous glucose monitoring (CGM) for diagnosis of gestational diabetes mellitus (GDM) improves maternal and neonatal outcomes related to GDM and to ...
Eligibility Criteria
Inclusion
- 24-30 weeks gestation undergoing GDM screening
Exclusion
- Known diagnosis of Type I and II DM
- History of bariatric surgery
- Major fetal anomalies
- Unwilling to use CGM for GDM screening
- Incarcerated subjects
- History of allergic reaction to any of CGM metals or adhesives in contact with the skin
Key Trial Info
Start Date :
March 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 16 2024
Estimated Enrollment :
1628 Patients enrolled
Trial Details
Trial ID
NCT05430204
Start Date
March 7 2023
End Date
September 16 2024
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030